| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.03 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.089 | 0.04 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.04 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |